Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has reported results for first quarter ended June 30, 2016.

The company has reported net loss at Rs 151.46 crore for the quarter as compared to net loss of Rs 396.35 crore for the same quarter in the previous year. Total income of the company decreased by 9.46% at Rs 1904.70 crore for quarter under review as compared to Rs 2103.67 crore for the quarter ended June 30, 2015.

On the consolidated basis, the company has reported over three fold jump in its net profit after taxes, minority interest share of profit of associates and joint ventures at Rs 2033.71 crore for the quarter ended June 30, 2016 as compared to Rs  555.90 crore for the same quarter in the previous year. However, total Income of the company increased by 21.29% to Rs 8400.09 crore for quarter under review from Rs 6925.60 crore for the quarter ended June 30, 2015.